TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Proteomics International Laboratories Ltd. ( (AU:PIQ) ) is now available.
Proteomics International Laboratories Ltd has released its preliminary final report for the financial year ending June 30, 2025. The company reported a revenue increase of 8% from ordinary activities compared to the previous year, reaching $960,389. However, the company also experienced a 27% increase in losses after tax, totaling $8,114,797. The report indicates a decrease in total revenue, including grants and other income, by 2% from the previous year. The company has announced that no dividends will be distributed for this period, and the Annual General Meeting is scheduled for November 21, 2025.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.43 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd is a company operating in the biotechnology industry, focusing on the development of analytical services and products related to proteomics, which is the large-scale study of proteins. The company is part of the PILL Group and is based in Australia.
Average Trading Volume: 368,695
Technical Sentiment Signal: Sell
Current Market Cap: A$51.56M
For an in-depth examination of PIQ stock, go to TipRanks’ Overview page.